Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Express Scripts
Harvard Business School

Last Updated: October 20, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Lobeline

See Plans and Pricing

« Back to Dashboard

Drug Development Status for Lobeline: Patents, clinical trial progress, indications

Lobeline is an investigational drug.

There have been 5 clinical trials for Lobeline. The most recent clinical trial was a Phase 2 trial, which was initiated on January 1st 2017.

The most common disease conditions in clinical trials are Attention Deficit Disorder with Hyperactivity, Amphetamine-Related Disorders, and Neoplasm Metastasis. The leading clinical trial sponsors are National Institute on Drug Abuse (NIDA), National Institute of Mental Health (NIMH), and Haining Health-Coming Biotech Co., Ltd.

Recent Clinical Trials for Lobeline
Clinical Studies by Using Accelerated PDX Model to Screen Drugs for Advanced Solid TumorHaining Health-Coming Biotech Co., Ltd.Phase 2
Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult PatientsNational Institute of Mental Health (NIMH)Phase 2
Effectiveness of Lobeline in Treating Symptoms of ADHD in Adult PatientsYaupon TherapeuticsPhase 2

See all Lobeline clinical trials

Clinical Trial Summary for Lobeline

Top disease conditions for Lobeline
Top clinical trial sponsors for Lobeline

See all Lobeline clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.